{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:57:57Z","timestamp":1774141077807,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.carrev.2026.01.001","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T07:38:55Z","timestamp":1767598735000},"page":"40-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Characteristic adverse events with the Arrow\u00ae AC3\u2122 Optimus\u2122 intra-aortic balloon pump (IABP): An analysis of the U.S. Food and Drug Administration MAUDE database from 2017 to 2025"],"prefix":"10.1016","volume":"84","author":[{"given":"Own","family":"Khraisat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Triston","family":"Messer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waleed","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmad","family":"Alqaseer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hashem","family":"Samardali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehab","family":"Alkhawaldeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farishta","family":"Saifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pranaychandra","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.carrev.2026.01.001_bb0005","first-page":"E168","article-title":"The current use of intra-aortic balloon counter pulsation","volume":"104","author":"Ferguson","year":"2001","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.carrev.2026.01.001_bb0010","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.carrev.2026.01.001_bb0015","series-title":"U.S. Food and Drug Administration Postmarket surveillance of medical devices","year":"2018"},{"key":"10.1016\/j.carrev.2026.01.001_bb0020","series-title":"U.S. Food and Drug Administration MAUDE\u2014manufacturer and user facility device experience","year":"2018"},{"issue":"5","key":"10.1016\/j.carrev.2026.01.001_bb0025","first-page":"606","article-title":"Mechanical circulatory support: past, present, and future","volume":"116","author":"Turi","year":"2007","journal-title":"Circulation"},{"issue":"56","key":"10.1016\/j.carrev.2026.01.001_bb0030","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.carrev.2023.05.432","article-title":"Characteristic adverse events with intra-aortic balloon pumps: an analysis of the U.S. Food and Drug Administration MAUDE database from 2016 to 2021","author":"Schwarzman","year":"2023","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.carrev.2026.01.001_bb0035","author":"Teleflex"},{"key":"10.1016\/j.carrev.2026.01.001_bb0040","author":"U.S. FDA"},{"key":"10.1016\/j.carrev.2026.01.001_bb0045","author":"Health Canada"},{"key":"10.1016\/j.carrev.2026.01.001_bb0055","author":"FDA"},{"issue":"4","key":"10.1016\/j.carrev.2026.01.001_bb0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2345\/0899-8205-46.4.268","article-title":"Monitor alarm fatigue: an integrative review","volume":"46","author":"Cvach","year":"2012","journal-title":"Biomed Instrum Technol"},{"key":"10.1016\/j.carrev.2026.01.001_bb0070","author":"MedTech Dive"},{"key":"10.1016\/j.carrev.2026.01.001_bb0075","author":"The Cardiology Advisor"},{"key":"10.1016\/j.carrev.2026.01.001_bb0080","author":"DiCardiology"},{"key":"10.1016\/j.carrev.2026.01.001_bb0085","author":"DiCardiology"},{"issue":"4","key":"10.1016\/j.carrev.2026.01.001_bb0090","first-page":"342","article-title":"Medical device surveillance\u2014understanding and using adverse event reports","volume":"351","author":"Maisel","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2026.01.001_bb0095","first-page":"348","article-title":"Challenges in evaluating medical device adverse event reports","volume":"33","author":"Ventola","year":"2008","journal-title":"PT"},{"key":"10.1016\/j.carrev.2026.01.001_bb0100","author":"de Oliveira"},{"issue":"2","key":"10.1016\/j.carrev.2026.01.001_bb0105","first-page":"145","article-title":"Monitor alarm fatigue: standardizing use of physiological monitors and decreasing nuisance alarms","volume":"21","author":"Cvach","year":"2012","journal-title":"Am J Crit Care"},{"key":"10.1016\/j.carrev.2026.01.001_bb0110","series-title":"Guidelines on alarm optimization, including customization, tiered alerting, and staff training, are recommended to mitigate alarm fatigue and ensure timely responses","year":"2013"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838926000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:33:47Z","timestamp":1774139627000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838926000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":20,"alternative-id":["S1553838926000011"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2026.01.001","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristic adverse events with the Arrow\u00ae AC3\u2122 Optimus\u2122 intra-aortic balloon pump (IABP): An analysis of the U.S. Food and Drug Administration MAUDE database from 2017 to 2025","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2026.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}